Author:
Choi Jin Woo,Park Ju-Hwan,Cho Hye Rim,Chung Jin Wook,Kim Dae-Duk,Kim Hyo-Cheol,Cho Hyun-Jong
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. World Health Organization Mortality Database. WHO Statistical Information System. http://www.who.int/whosis (2008).
2. Bruix, J. & Sherman, M. Management of hepatocellular carcinoma: An update. Hepatology 53, 1020–1022, doi: 10.1002/hep.24199 (2011).
3. Luigi et al. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: Proposal for a subclassification to facilitate treatment decisions. Semin. Liver Dis. 32, 348–359 (2012).
4. Park, M. et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 35, 2155–2166, doi: 10.1111/liv.2015.35.issue-9 (2015).
5. Cammà, C. et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224, 47–54, doi: 10.1148/radiol.2241011262 (2002).